The fibrinogen prothrombin time ‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban

Journal of Thrombosis and Haemostasis, EarlyView.

Source: Journal of Thrombosis and Haemostasis - June 25, 2018 Category: Hematology Authors: C. Duboscq , M. E. Martinuzzo , J. Ceresetto , M. Lopez , L. Barrera , J. Oyhamburu , G. Stemmelin Source Type: research